Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis 24-week data from the SIMPACT study /
The aim of the SIMPACT study was to evaluate the efficacy and safety of MTX-free s.c. tocilizumab (TCZ) therapy in RA patients.SIMPACT was an open-label, non-controlled, non-randomized, non-interventional study, in which RA patients for whom the treating physicians ordered s.c. TCZ were observed dur...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2022
|
| Sorozat: | Rheumatology Advances in Practice
6 No. 2 |
| Tárgyszavak: | |
| doi: | 10.1093/rap/rkac038 |
| mtmt: | 32866658 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/24509 |